US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
FiercePharma1d
Johnson & Johnson tacks on another NSCLC approval in pursuit of AstraZeneca's Tagrisso
Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...
FiercePharma3d
AstraZeneca's Fasenra plays catch-up with GSK's Nucala, gaining FDA nod for rare autoimmune disease
Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart ... On establishing non-inferiority on the trial’s ...
AstraZeneca PLC (AZN) Meet the Management at ESMO 2024 Conference (Transcript)
Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...
BioSpace5d
AstraZeneca’s Perioperative Imfinzi ‘Significantly Extends Survival’ in Type of Bladder Cancer
A perioperative regimen of PD-L1 blocker Imfinzi yielded “clinically meaningful” survival benefits for patients with ...